Work Packages

MpoxVax AFRIVAC





Work Package 1

Project Management and Consortium Coordination 


WP1 comprises all managerial and coordination activities to ensure this interdisciplinary project is well- coordinated scientifically and well-managed operationally, and that its achievements are adequately disseminated and communicated to the stakeholders, the research community, healthcare professionals and the society.

WP lead and Project Coordinator: UCD 

Prof Patrick Mallon


Work Package 2

 Scientific Project Leadership and Clinical Trial


WP2 will adapt and conduct the MpoxVax clinical trial for the evaluation of humoral immune responses of participants at risk of Mpox infection receiving the modified vaccinia ankara (MVA) vaccine in Uganda, Tanzania and DRC.

WP lead and Scientific Coordinator: MLI

Prof Bruce Kirenga

Co-Lead: UCD
 Prof Eoin Feeney


Work Package 3

 Laboratory assays and biobanking 

WP3 will set up the laboratory assay harmonisation programme including quality control/ quality assuranceamong the participating laboratories and will adapt and validate the novel serological immunoassay developed by CEPHR in the African setting.

WP Lead: UNHRO

Dr Andrew Obuku


Work Package 4

 Community Engagement, Training and Dissemination 

WP4 will be responsible for Community Engagement, ensuring the participants’ and the public’s views areconsidered and represented, as well as for knowledge Exchange and technology transfer between European and African partners and project finding dissemination.

WP Lead: USTAN

Dr Wilber Sabiiti